"Singletto partners with top brands to transform products into COVID killers using OxyFence technology."
Every day, average citizens face a host of harmful pathogens from the common cold and seasonal flu to the life-disrupting COVID-19 virus. Bacteria, viruses, and other pathogens are a part of daily life.
Similarly, a host of anti-bacterial and anti-viral disinfectants are available for surfaces and hands contaminated with these specific pathogens. Most current solutions, however, decontaminate after infection; novel solutions are needed to both decontaminate and offer continuous protection.
Deploying principles of Photodynamic Therapy (PDT), typically used for fighting cancer, Singletto experts are creating solutions that provide decontamination and active, ongoing protection from COVID-19, and other pathogens.
Singletto works with healthcare-focused and general consumer brands and manufacturers to provide solutions for their existing and future products, technology, and systems by licensing its proprietary OxyFence™ technology.
Our experts in pathogen-destroying singlet oxygen work with partners to create optimal effectiveness and quality design for consumer products.
Our PDT labs validate singlet oxygen generation, our virology labs confirm COVID-19 and other pathogen protection, and our 3rd party partners ensure efficacy.
Our standard is safety. If a product offers OxyFence™ protection, it means we have researched, tested, and validated its efficacy.
The Singletto team of Photodynamic Therapy (PDT) experts, chemists, virologists, surgeons, and researchers are using light-activated dyes to generate singlet oxygen that destroys pathogens, including the common cold, seasonal flu, and COVID-19. We’re partnering with trusted brands to enhance everyday products with this pathogen-fighting technology. Learn more about OxyFence.